Skip to main content
SpringerLink
Log in
Book cover

Störungen der Motilität des oberen Gastrointestinaltraktes pp 81–99Cite as

Möglichkeiten, die gastrointestinale Motilität pharmakologisch zu beeinflussen — Rückblick und Ausblick

  • Conference paper

  • 11 Accesses

Zusammenfassung

Die physiologische Kontrolle der gastrointestinalen (GI) Motilität involviert regulatorische Prozesse in verschiedenen Ebenen (Abb. 1). Eine pharmakologische Stimulation der GI-Motilität kann in jeder dieser Ebenen vorgenommen werden. Der meist beschrittene und erfolgreichste Weg scheint ein Eingriff auf der Ebene des enterischen Nervensystems (ENS) zu sein.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Champion MC (1988) Domperidone. Gen Pharmacol 19:499–505

    Article  PubMed  CAS  Google Scholar 

  • Costall B, Naylor RJ (1990) 5-hydroxytryptamine: new receptors and novel drugs for gastrointestinal motor disorders. Scand J Gastroenterol 25:769–787

    Article  PubMed  CAS  Google Scholar 

  • Craig DA, Clarke DE (1990) Pharmacological characterization of a neuronal receptor for 5-hydroxytryptamine in guinea pig ileum with properties similar to the 5-hydroxytryptamine 4 receptor. J Pharmacol Exp Ther 252:1378–1386

    PubMed  CAS  Google Scholar 

  • Craig DA, Clarke DE (1991) Peristalsis evoked by 5HT and renza- pride: evidence for putative 5HT4 receptor activation. Br J Pharmacol 102:563–564

    PubMed  CAS  Google Scholar 

  • Debas HT, Farooq O, Grossman MI (1975) Inhibition of gastric emptying is a physiological action of cholecystokinin. Gastroenterology 68:1211–1217

    PubMed  CAS  Google Scholar 

  • Depoortere I, Peeters TL,Vantrappen G (1991) Evidence for motilin receptor subtypes in the rabbit. J GI Motil 3:179

    Google Scholar 

  • Dhasmana Banerjee AK, Zhu YN, Erdmann W (1989) Role of dopamine receptors in gastrointestinal motility. Res Commun Chem Pathol Pharmacol 64:485–488

    PubMed  CAS  Google Scholar 

  • Doty JE, Sanders SL, Gu YG, Lin HC (1990) Erythromycin accelerates gastric emptying of solids at the expense of sieving. Gastroenterology 98:A349

    Google Scholar 

  • Dumuis A, Sebben M, Bockaert J (1989) The gastrointestinal proki- netic benzamide derivatives are agonists at the non-classical 5HT receptor (5HT4) positively coupled to adenylate cyclase in neurons. Naun-Schmiedebergs Arch Pharmacol 340:403–410

    Article  CAS  Google Scholar 

  • Fozard JR, Mobarak Ali ATM (1978) Blockade of neuronal trypt- amine receptors by metoclopramide. Eur J Pharmacol 49:109–112

    Article  PubMed  CAS  Google Scholar 

  • Fried M, Erlacher U, Schwizer Wet al. (1991) Role of cholecystokinin in the regulation of gastric emptying and pancreatic enzyme secretion in humans. Gastroenterology 101:503–511

    PubMed  CAS  Google Scholar 

  • Goyal RK (1988) Identification, localization and classification of muscarinic receptor subtypes in the gut. Life Sci 43:2209–2220

    Article  PubMed  CAS  Google Scholar 

  • Goyal RK (1989) Muscarinic receptor subtypes. Physiology and clinical implications. N Engl J Med 321:1022–1029

    Article  PubMed  CAS  Google Scholar 

  • Hellenbrecht D (1990) Pharmakologie von Prokinetika. In: Hotz J (Hrsg) Motilitätsstörungen im oberen Gastrointestinaltrakt. Pathophysiologic, Pharmakologie und Differentialtherapie. Springer, Berlin Heidelberg New York, S 1–26

    Google Scholar 

  • Huizinga JD (1991) Action potentials in gastrointestinal smooth muscle. Can J Physiol Pharmacol 69:1133–1142

    Article  PubMed  CAS  Google Scholar 

  • Inatomi N, Satoh H, Maki Yet al. (1989) An erythromycin derivative, EM-523, induces motilin-like gastrointestinal motility in dogs. J Pharm Exp Ther 251:707–712

    CAS  Google Scholar 

  • Innis RB, Snyder SH (1980) Distinct cholecystokinin receptors in brain and pancreas. Proc Natl Acad Sci USA 77:6917–6921

    Article  PubMed  CAS  Google Scholar 

  • Itoh Z, Nakaya M, Suzuki T et al. (1984) Erythromycin mimics exogenous motilin in gastrointestinal contractile activity in the dog. Am J Physiol 247:G688-G694

    PubMed  CAS  Google Scholar 

  • Iwanaga Y, Miyashita N, Morikawa K et al. (1990) A novel water- soluble dopamine 2-antagonist with anticholinesterase activity in gastrointestinal motor activity. Comparison with domperidone and neostigmine. Gastroenterology 99:401–408

    PubMed  CAS  Google Scholar 

  • Janssens J, Peeters TL, Van trappen G et al. (1990) Improvement of gastric emptying in diabetic gastroparesis by erythromycin. N Engl J Med 322:1028–1031

    Article  PubMed  CAS  Google Scholar 

  • King FD, Sanger GJ (1989) 5HT3 receptor antagonists. Drugs Future 14:875–889

    Google Scholar 

  • Kusonoki M, Taniyama K, Tanaka C (1985) Dopamine regulation of [3H]acetylcholine release from guinea pig stomach. J Pharmacol Exp Ther 234:713–719

    Google Scholar 

  • Liberge M, Droy-Lefaux MT, Jutteau J, Bueno L (1990) BIM-18216 antagonizes the inhibition of gastric emptying induced by CCKg and fat in mice. Digestion 46 (Suppl 1):62

    Google Scholar 

  • Liddle RA, Morita ET, Conrad CK, Williams JA (1986) Regulation of gastric emptying in humans by cholecystokinin. J Clin Invest 77:992–996

    Article  PubMed  CAS  Google Scholar 

  • Liddle RA, Gertz BJ, Kanayama S et al. (1989) Effects of a novel cholecystokinin (CCK) receptor antagonist MK 329, on gallbladder contraction and gastric emptying in humans. Implications for the physiology of CCK. J Clin Invest 84:1220–1225

    Article  PubMed  CAS  Google Scholar 

  • Lotti VJ, Pendleton RG, Gould RJ et al. (1987) In vivo pharmacology of L-364, 718, a new potent non-peptide peripheral cholecystokinin antagonist. J Pharmacol Exp Ther 241:103–109

    PubMed  CAS  Google Scholar 

  • Mawe GM, Branchek TA, Gershon MD (1989) Blockade of 5-HT mediated enteric slow EPSPs by BRL 24924: gastrokinetic effects. Am J Physiol 257:G386-G396

    PubMed  CAS  Google Scholar 

  • McCallum RW, Fink SM, Lerner E, Berkowitz DM (1983) Effects of metoclopramide and bethanechol on delayed gastric emptying present in gastroesophageal reflux patients. Gastroenterology 84:1573–1577

    PubMed  CAS  Google Scholar 

  • Pascaud X, Hönde C, Le Gallou B et al. (1990) Effects of fedotozine on gastrointestinal motility in dogs: mechanism of action and related pharmacokinetics. J Pharm Pharmacol 42:546–552

    Article  PubMed  CAS  Google Scholar 

  • Richardson BP, Engel G, Donatsch P, Stadler PA (1985) Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature 316:126–131

    Article  PubMed  CAS  Google Scholar 

  • Ruoff HJ, Fladung B, Demol P,Weihrauch TR (1991) Gastrointestinal receptors and drugs in motility disorders. Digestion 48:1–17

    Article  PubMed  CAS  Google Scholar 

  • Sanders KM, Publicover NG (1989) Electrophysiology of the gastric musculature. In: Schulz SG, Wood JD, Rauner BB (eds) Handbook of physiology, sec 6. The gastrointestinal system, vol 1 (1). Am Physiol Soc, pp 187–216

    Google Scholar 

  • Schiavone A, Volonte M, Micheletti R (1990) The gastrointestinal motor effect of benzamide derivatives is unrelated to 5HT3 receptor blockade. Eur J Pharmacol 187:323–329

    Article  PubMed  CAS  Google Scholar 

  • Schulze-Delrieu K (1979) Metoclopramide. Gastroenterology 77: 768–779

    PubMed  CAS  Google Scholar 

  • Schuurkes JA J, van Neuten JM (1990) Pharmacological modulation of gastro-duodenal coordination. In: van Neuten JM, Schuurkes JAJ, Akkermans LMA (eds) Gastro-pyloroduodenal coordination. Wright- son Biomedical Publ, Petersfield, pp 155–166

    Google Scholar 

  • Takaki M, Branchek T, Tamir H, Gershon MD (1985) Specific antagonism of enteric neural serotonin receptors by dipeptides of 5-hydroxytryptophan: evidence that serotonin is a mediator of slow synaptic excitation in the myenteric plexus. J Neurosci 5:1767–1780

    Google Scholar 

  • Valenzuela JE (1976) Dopamine as a possible neurotransmitter in gastric relaxation. Gastroenterology 71:1019–1022

    PubMed  CAS  Google Scholar 

  • Wade PR, Gershon MD (1991) Subtypes of 5-HT receptor in the peristaltic reflex of the guinea pig. J GI Motil 3:206

    Google Scholar 

  • Yamagashi T, Debas HT (1978) Cholecystokinin inhibits gastric emptying by acting on both proximal stomach and pylorus. Am J Physiol 234:E375-E378

    Google Scholar 

Download references

Authors
  1. P. G. Gregory
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Abteilung Gastroenterologie, Zentrum für innere Medizin, Universitäts-Klinikum Essen, Hufelandstraße 55, 4300, Essen 1, Deutschland

    Harald Goebell (Direktor) & Peter Layer (Direktor) & 

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Gregory, P.G. (1992). Möglichkeiten, die gastrointestinale Motilität pharmakologisch zu beeinflussen — Rückblick und Ausblick. In: Goebell, H., Layer, P. (eds) Störungen der Motilität des oberen Gastrointestinaltraktes. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77589-5_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-77589-5_6

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-55584-1

  • Online ISBN: 978-3-642-77589-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation